Income Statement (TTM)
SCHOTT Pharma AG & Co. KGaA - Depositary Receipt (Common Stock) Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2021 09-30 |
2022 09-30 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 584 | 649 | 821 | 873 | 899 | 906 | 916 | 949 | 957 | 955 | 973 | 976 |
| Change (%) | 11.03 | 26.59 | 6.33 | 2.92 | 0.78 | 1.18 | 3.52 | 0.90 | -0.25 | 1.90 | 0.30 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 388 | 422 | 525 | 568 | 582 | 587 | 605 | 624 | 634 | 639 | 653 | 647 |
| Change (%) | 8.83 | 24.14 | 8.29 | 2.49 | 0.77 | 3.16 | 3.18 | 1.62 | 0.75 | 2.11 | -0.94 | |
| % of Revenue | 66.45 | 65.13 | 63.87 | 65.05 | 64.78 | 64.77 | 66.04 | 65.82 | 66.29 | 66.96 | 67.10 | 66.27 |
| Gross Operating Profit | 196 | 226 | 297 | 305 | 316 | 319 | 311 | 324 | 323 | 315 | 320 | 329 |
| Change (%) | 15.39 | 31.16 | 2.86 | 3.72 | 0.80 | -2.45 | 4.18 | -0.49 | -2.23 | 1.47 | 2.82 | |
| % of Revenue | 33.55 | 34.87 | 36.13 | 34.95 | 35.22 | 35.23 | 33.96 | 34.18 | 33.71 | 33.04 | 32.90 | 33.73 |
| SG&A | 90 | 92 | 111 | 123 | 123 | 124 | 125 | 126 | 125 | 126 | 128 | 129 |
| Change (%) | 3.20 | 19.77 | 10.69 | 0.05 | 1.17 | 0.58 | 0.84 | -0.56 | 0.80 | 1.35 | 0.50 | |
| % of Revenue | 15.34 | 14.26 | 13.49 | 14.04 | 13.65 | 13.70 | 13.62 | 13.27 | 13.08 | 13.22 | 13.15 | 13.17 |
| R&D | 24 | 22 | 24 | 24 | 27 | 27 | 28 | 27 | 24 | 25 | 25 | 27 |
| Change (%) | -5.48 | 5.55 | 3.81 | 9.82 | -1.20 | 4.77 | -3.15 | -9.80 | 3.29 | 1.22 | 6.35 | |
| % of Revenue | 4.04 | 3.44 | 2.87 | 2.80 | 2.98 | 2.93 | 3.03 | 2.83 | 2.53 | 2.62 | 2.61 | 2.76 |
| OpEx | 493 | 534 | 653 | 709 | 727 | 735 | 745 | 773 | 768 | 774 | 790 | 777 |
| Change (%) | 8.29 | 22.27 | 8.49 | 2.66 | 0.98 | 1.45 | 3.78 | -0.66 | 0.78 | 2.05 | -1.68 | |
| % of Revenue | 84.43 | 82.35 | 79.54 | 81.15 | 80.95 | 81.11 | 81.32 | 81.53 | 80.27 | 81.10 | 81.22 | 79.62 |
| Operating Income | 91 | 114 | 168 | 165 | 171 | 171 | 171 | 175 | 189 | 180 | 183 | 199 |
| Change (%) | 25.87 | 46.73 | -2.06 | 4.04 | -0.06 | 0.03 | 2.38 | 7.76 | -4.43 | 1.23 | 8.85 | |
| % of Revenue | 15.57 | 17.65 | 20.46 | 18.85 | 19.05 | 18.89 | 18.68 | 18.47 | 19.73 | 18.90 | 18.78 | 20.38 |
| Interest Expense | -2 | -1 | -2 | -5 | -7 | -8 | -9 | -11 | -13 | -15 | -17 | -18 |
| Change (%) | -21.56 | 78.25 | 153.55 | 24.25 | 18.92 | 17.02 | 18.06 | 16.79 | 17.59 | 12.81 | 7.38 | |
| % of Revenue | -0.26 | -0.18 | -0.26 | -0.61 | -0.74 | -0.87 | -1.01 | -1.15 | -1.34 | -1.57 | -1.74 | -1.87 |
| Net Income | 77 | 101 | 125 | 143 | 152 | 158 | 135 | 150 | 150 | 134 | 148 | 147 |
| Change (%) | 30.04 | 24.44 | 13.84 | 6.39 | 4.13 | -14.85 | 11.72 | -0.48 | -10.37 | 9.99 | -0.47 | |
| % of Revenue | 13.26 | 15.53 | 15.27 | 16.35 | 16.90 | 17.46 | 14.69 | 15.86 | 15.64 | 14.05 | 15.17 | 15.05 |
Source: Capital IQ
